Welcome to LookChem.com Sign In|Join Free

CAS

  • or

27305-48-2

Post Buying Request

27305-48-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

27305-48-2 Usage

Class

Aromatic heterocyclic compounds

Subclass

Naphthyridines

Type

N-oxide derivative

Structure

Contains an oxygen atom bonded to the nitrogen atom within the naphthyridine ring

Potential applications

Pharmaceutical and agrochemical industries, research and development

Unique properties

Interesting molecule for further study and potential use in various chemical and biological processes

Check Digit Verification of cas no

The CAS Registry Mumber 27305-48-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,7,3,0 and 5 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 27305-48:
(7*2)+(6*7)+(5*3)+(4*0)+(3*5)+(2*4)+(1*8)=102
102 % 10 = 2
So 27305-48-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H6N2O/c11-10-6-2-3-7-8(10)4-1-5-9-7/h1-6H

27305-48-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-oxido-1,5-naphthyridin-1-ium

1.2 Other means of identification

Product number -
Other names 1,5-naphthyridine N-(1)-oxide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:27305-48-2 SDS

27305-48-2Relevant articles and documents

-

Brown,Plasz

, p. 241 (1967)

-

SUBSTITUTED 1,5-NAPHTHYRIDINES OR QUINOLINES AS ALK5 INHIBITORS

-

Paragraph 226; 254; 265, (2021/05/29)

The present disclosure provides inhibitors of activin receptor-like kinase 5 (ALK5). Also disclosed are methods to modulate the activity of ALK5 and methods of treatment of disorders mediated by ALK5.

HETEROARYL COMPOUNDS AS CXCR4 INHIBITORS, COMPOSITION AND METHOD USING THE SAME

-

Paragraph 00309-00311, (2019/04/16)

The present disclosure provides heteroaryl compounds of Formula (I), processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of diseases and disorders, arising from or related to the CXCR4 pathway.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 27305-48-2